Non-Current Assets

Goodwill

Quest Diagnostics Goodwill increased by 2.0% to $9.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.1%, from $8.85B to $9.12B. Over 5 years (FY 2020 to FY 2025), Goodwill shows an upward trend with a 5.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026

How to read this metric

A significant increase indicates recent M&A activity, while a sudden decrease typically signals an impairment charge due to underperforming acquisitions.

Detailed definition

Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...

Peer comparison

Standard metric for companies that grow through acquisition; comparable across all industries.

Metric ID: goodwill

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$7.05B$7.06B$7.10B$7.20B$7.20B$7.19B$7.22B$7.24B$7.73B$7.73B$7.73B$7.83B$7.89B$8.61B$8.86B$8.85B$8.88B$8.90B$8.95B$9.12B
QoQ Change+0.2%+0.5%+1.4%-0.0%-0.1%+0.4%+0.3%+6.8%-0.0%+0.0%+1.3%+0.7%+9.1%+2.9%-0.1%+0.4%+0.2%+0.5%+2.0%
YoY Change+2.1%+1.9%+1.8%+0.6%+7.5%+7.5%+7.1%+8.1%+2.0%+11.3%+14.5%+13.0%+12.7%+3.4%+1.0%+3.1%
Range$7.05B$9.12B
CAGR+5.6%
Avg YoY Growth+6.1%
Median YoY Growth+5.3%
Current Streak4 quarters growth

Frequently Asked Questions

What is Quest Diagnostics's goodwill?
Quest Diagnostics (DGX) reported goodwill of $9.12B in Q1 2026.
How has Quest Diagnostics's goodwill changed year-over-year?
Quest Diagnostics's goodwill increased by 3.1% year-over-year, from $8.85B to $9.12B.
What is the long-term trend for Quest Diagnostics's goodwill?
Over 5 years (2020 to 2025), Quest Diagnostics's goodwill has grown at a 5.4% compound annual growth rate (CAGR), from $6.87B to $8.95B.
What does goodwill mean?
The excess price paid for an acquisition over the fair value of its net assets.